![\"tablets\"](\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/06\/tablets.jpg\" "\\"Credit:")
<\/p>\n\n\t\t\t\t\t\t\t\t\t\t\tby David J. Neal\t\t\t\t\t\t\t\t\t<\/p>\n
<\/p>\n
Credit: Unsplash\/CC0 Public Domain<\/p>\n
Three lots of a drug designed to treat various urinary tract infections have been recalled because the white round tablets might have black spots from microbial contamination.<\/p>\n
The appearance of spots “was reported in a product quality complaint,” Amneal Pharmaceuticals said in its FDA-posted recall notice about Sulfamethoxazole\/Trimethoprim Tablets, USP, 400 mg\/80 mg.<\/p>\n
As for what problems this might cause, Amneal’s notice said, “Oral products contaminated with Aspergillus may result in serious and life-threatening infections. The use of the defective product in patients with underlying immunosuppressive conditions increases the concern for serious infections.”<\/p>\n
Sulfamethoxazole\/Trimethoprim is used for UTIs caused by a broad list of strains, among which are E. coli; middle-ear infections in children; streptococcus pneumoniae<\/a> aka pneumococcus, which the Cleveland Clinic says can cause pneumonia, sepsis or bacterial meningitis<\/a>; and “traveler’s diarrhea.”<\/p>\n Recalled tablets with 400 mg of Sulfamethoxazole and 80 mg Trimethoprim went to wholesalers and distributors around the nation from Dec. 4 through May 15. If you have these tablets but got them before Dec. 4, you’re safe.<\/p>\n \n 2025 Miami Herald. Distributed by Tribune Content Agency, LLC.\n <\/p>\n \n Citation<\/strong>: \n This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
\n Urinary tract infection drug recalled (2025, June 6)
\n retrieved 7 June 2025
\n from https:\/\/medicalxpress.com\/news\/2025-06-urinary-tract-infection-drug-recalled.html\n <\/p>\n
\n part may be reproduced without the written permission. The content is provided for information purposes only.\n <\/p>\n","protected":false},"excerpt":{"rendered":"by David J. Neal Credit: Unsplash\/CC0 Public Domain Three lots of a drug designed to treat various urinary…\n","protected":false},"author":2,"featured_media":166028,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[105,1555,1554,1556,4326,1553,1552,1557,16,15],"class_list":{"0":"post-166027","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-health-research","10":"tag-health-research-news","11":"tag-health-science","12":"tag-medication","13":"tag-medicine-research","14":"tag-medicine-research-news","15":"tag-medicine-science","16":"tag-uk","17":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114644323202979785","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/166027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=166027"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/166027\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/166028"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=166027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=166027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=166027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}